Evonik, Fufeng Partner to Produce L-Threonine

Evonik Industries AG and the Fufeng Group have entered into a cooperation agreement for the production of ThreAMINO (L-threonine). The renowned Chinese specialist in bio-fermentation will toll manufacture ThreAMINO for Evonik using Evonik’s technology.

This strategic partnership supports Evonik’s positioning and efficiency in the animal nutrition segment. For the first time, Evonik is now able to offer ThreAMINO worldwide with a lean asset footprint.

The Junan-based Fufeng Group operates several large-scale production facilities in Northern China and counts as the world’s largest producer of starch-based food and feed ingredients with a strong record of manufacturing fermentative feed additives. The collaboration with Evonik enables Fufeng to assume an important role in supplying amino acids.

L-Threonine, marketed as ThreAMINO by Evonik, is an essential amino acid that the body cannot produce itself. It must therefore be taken up by the animals with the feed. An optimal L-threonine level improves feed intake, weight gain and nutritional value of the feed. In contrast, nitrogen excretion decreases because the crude protein content of the feed is balanced according to the nutrient requirements of the animals.

"Our strategy reflects the recent dynamics of the feed amino acids market and helps Evonik to further optimize its bio amino acid business. The agreement with Fufeng enables us to provide our full portfolio of amino acids to all of our customers. This way, we’re supporting our position in Western and Asian markets and transforming our business model by focusing on our value creating strengths in sales, services and technology,” said Dr Emmanuel Auer, head of the animal nutrition business line at Evonik.

"This collaboration is a good example of how two strong partners join forces. By working together, we build the foundation for a long-lasting and trusting strategic partnership," added Zhao Qiang, CEO of Fufeng Group.